Article
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 1 Nov 2015
Dong Bingzi, Endo Itsuro, Ohnishi Yukiyo, Kondo Takeshi, Hasegawa Tomoka, Amizuka Norio, Kiyonari Hiroshi, Shioi Go, Abe Masahiro, Fukumoto Seiji, Matsumoto Toshio
Abstract excerpt
Activating mutations of calcium-sensing receptor (CaSR) cause autosomal dominant hypocalcemia (ADH). ADH patients develop hypocalcemia, hyperphosphatemia, and hypercalciuria, similar to the clinical features of hypoparathyroidism. The current treatment of ADH is similar to the other forms of hypoparathyroidism, using active vitamin D3 or parathyroid hormone (PTH). However, these treatments aggravate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
